Cargando…

Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, Volume II

Detalles Bibliográficos
Autores principales:	Pereira, Marta P., García-Bueno, Borja, Caso, Javier R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102634/ https://www.ncbi.nlm.nih.gov/pubmed/37063292 http://dx.doi.org/10.3389/fphar.2023.1191907

Ejemplares similares

Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, volume I
por: Pereira, Marta P., et al.
Publicado: (2022)

Editorial: Women in neuropharmacology: 2021
por: Vohora, Divya, et al.
Publicado: (2023)

Editorial: Case reports in neuropharmacology 2022
por: Preda, Adrian
Publicado: (2023)

Editorial: Novel Approaches to the Neuropharmacology of Mood Disorders
por: Caruncho, Hector J., et al.
Publicado: (2019)

Editorial: Neuropharmacological, Neurobiological and Behavioral Mechanisms of Learning and Memory
por: Meneses, Alfredo, et al.
Publicado: (2019)

Editorial: Neuropharmacology of neuro -degenerative, -logical, -psychiatric disorders
por: Kaur, Harpreet
Publicado: (2023)

Editorial: Be positive about the negative in pharmacology: Neuropharmacology 2022
por: Preda, Adrian, et al.
Publicado: (2023)

Cistanches Herba: A Neuropharmacology Review
por: Gu, Caimei, et al.
Publicado: (2016)

Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain
por: Lione, Lisa A., et al.
Publicado: (2022)

Editorial: Insights on neuroinflammatory response by microglia-targeted pharmacology
por: Raber, Jacob, et al.
Publicado: (2023)

Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders
por: Peng, Ye, et al.
Publicado: (2021)

Commentary: Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders
por: Wang, Yufang, et al.
Publicado: (2021)

Neuropharmacological Effects of Quercetin: A Literature-Based Review
por: Islam, Md. Shahazul, et al.
Publicado: (2021)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Differentiating the Neuropharmacological Properties of Nicotinic Acetylcholine Receptor-Activating Alkaloids
por: Alijevic, Omar, et al.
Publicado: (2022)

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective
por: Šíma, Martin, et al.
Publicado: (2023)

Antinociceptive and neuropharmacological activities of methanol extract of Phoenix sylvestris fruit pulp
por: Shajib, Md. Shafiullah, et al.
Publicado: (2015)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Polymethoxyflavones from Nicotiana plumbaginifolia (Solanaceae) Exert Antinociceptive and Neuropharmacological Effects in Mice
por: Shajib, Md. Shafiullah, et al.
Publicado: (2018)

Neuropharmacological efficacy of metformin for stroke in rodents: A meta-analysis of preclinical trials
por: Fu, Wenqiao, et al.
Publicado: (2022)

Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy
por: Sadanandan, Nadia, et al.
Publicado: (2021)

Editorial: Biomarkers in neurology, volume II
por: Mohamed, Wael M. Y., et al.
Publicado: (2023)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Editorial: Experimental models of epilepsy and related comorbidities, Volume II
por: Shaikh, Mohd Farooq, et al.
Publicado: (2023)

Editorial: Medication safety in COVID-19 management, Volume II
por: Das, Saibal
Publicado: (2023)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders
por: Jakaria, Md., et al.
Publicado: (2018)

Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation
por: Murru, Elisabetta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g0na9t3jefssa41qcstk1o0utt